October 4-5, 2021
The MidWest Drug Development Conference is a highly focused event condensing the best therapeutic research from a vast region into a singular event. More than a dozen major institutions will present some of their best therapeutic programs and assets.
About 50 technologies, delivered in 10-minute presentations, will span a broad range of indications including: inflammatory diseases, infectious diseases, cancer, metabolic diseases, and cardiovascular disease.
The MidWest Drug Development Conference is ideal for pharmaceutical companies and investor groups looking to identify new therapeutic assets and partnering opportunities.
These major institutions are already planning to present their most promising therapeutic innovations, and even more are expected to join:
- Kansas State University
- Mayo Clinic
- Ohio State University
- Purdue University
- University of Colorado-Anschutz Medical Campus
- University of Iowa
- University of Kansas
- University of Kentucky
- University of Missouri
- University of Nebraska Medical Center
- University of Oklahoma
- Wisconsin Alumni Research Foundation (WARF)
Meet the researchers, connect with tech transfer professionals and build connections that could create new, ground-breaking collaborations. Space will be dedicated to the sole purpose of networking with university, industry and investor guests who want to engage in one-on-one partnering discussions.
Sponsor Opportunities Available – Learn More